iShares US Pharmaceuticals ETF
IHE
IHE
128 hedge funds and large institutions have $117M invested in iShares US Pharmaceuticals ETF in 2023 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 15 increasing their positions, 34 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
56% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 34
Holders
128
Holding in Top 10
–
Calls
$320K
Puts
–
Top Buyers
| 1 | +$6.52M | |
| 2 | +$1.3M | |
| 3 | +$610K | |
| 4 |
OCM
One Capital Management
Westlake Village,
California
|
+$379K |
| 5 |
SWA
Stratos Wealth Advisors
Beachwood,
Ohio
|
+$330K |
Top Sellers
| 1 | -$4.48M | |
| 2 | -$3.59M | |
| 3 | -$3.54M | |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$997K |
| 5 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
-$986K |